Codex DNA, Inc. (DNAY) Balance Sheet Quarterly

Codex DNA, Inc.

DNAY (NASDAQ)

(%)

Financials
Codex DNA, Inc. Balance Sheet Statement Quarterly

Annual Quarterly

* (except for per share items) of USD

Period Ending:	2024 (Q3) 09-30	2024 (Q2) 06-30	2023 (Q3) 09-30	2023 (Q2) 06-30	2023 (Q1) 03-31	2022 (Q4) 12-31	2022 (Q3) 09-30
Report Filing:	2024-11-07	2024-08-08	2023-11-13	2023-08-11	2023-05-12	2023-03-22	1234
Total Current Assets	8.12	15.16	52.71	61.54	42.94	55.09	1234
Cash and Short Term Investments	4.51	10.21	41.45	47.35	32.07	43.58	1234
Cash & Equivalents	3.72	6.4	17.39	46.61	23.36	30.42	1234
Short Term Investments	0.794	3.82	24.06	0.747	8.71	13.16	1234
Receivables	1.26	1.33	5.36	8.24	5.83	5.85	1234
Inventory	1.1	1.36	4.27	3.86	2.29	2.2	1234
Other Current Assets	1.25	2.25	1.63	2.09	2.74	3.46	1234
Total Assets	24.74	52.73	105	114.5	89.16	81.36	1234
Total Non-Current Assets	16.62	37.57	52.32	52.98	46.22	26.27	1234
Property, Plant and Equipment	11.99	30.98	35.08	35.5	28.6	8.52	1234
Goodwill and Intangible Assets	4.13	4.25	16.38	16.51	16.64	16.77	1234
Goodwill	3.5	3.5	14.89	14.89	14.89	14.89	1234
Intangible Assets	0.638	0.75	1.5	1.62	1.75	1.88	1234
Long Term Investments	0	0	0	0	0	0	1234
Deferred Tax Assets	0	0	0	0	0	0	1234
Other Long Term Assets	0.491	2.34	0.852	0.973	0.981	0.981	1234
Total Current Liabilities	6.63	8.01	25.42	10.39	11.24	13.5	1234
Accounts Payable	1.49	1.54	2.4	1.43	2.44	1.29	1234
Notes Payable/Short Term Debt	2.21	1.79	16.95	1.55	0.774	0.637	1234
Tax Payables	0	0	0	0	0	0	1234
Deferred Revenue	0.263	0.38	1.18	2.17	2.98	3.96	1234
Other Current Liabilities	2.67	4.3	4.89	5.23	5.05	7.61	1234
Total Liabilities	20.86	42.78	58.54	58.46	52.54	34.8	1234
Total Non-Current Liabilities	14.23	34.77	33.12	48.07	41.3	21.3	1234
Total Long Term Debt	14.09	33.76	32.96	47.71	40.94	20.79	1234
Deferred Tax Liabilities Non-Current	0	0	0	0	0	0	1234
Deferred Revenue Non-Current	0	0.099	0.118	0.149	0.134	0.142	1234
Capital Lease Obligations	0	0	0	0	0	0	1234
Other Long Term Liabilities	0.149	0.91	0.041	0.208	0.227	0.367	1234
Total Equity	0	0	17.77	27.92	36.62	46.56	1234
Non-Controlling Interest	0	0	0	0	0	0	1234
Total Stockholders' Equity	-27.22	-20.54	17.77	27.92	36.62	46.56	1234
Retained Earnings	-189.3	-182.7	-143.8	-133.1	-124.9	-113.7	1234
Accumulated Other Earnings	-0.005	-0.009	-0.015	-28.15	0.002	0	1234
Common Stock	0	0	0.005	0.005	0.005	0.005	1234
Preferred Stock	31.1	30.48	28.72	28.15	0	0	1234
Additional Paid in Capital	162.1	162.2	132.8	161.1	161.5	160.3	1234
Total Liabilities & Total Equity	-6.36	52.73	105	114.5	89.16	81.36	1234
Total Liabilities & Shareholders' Equity	24.74	52.73	105	114.5	89.16	81.36	1234
Total Investments	0.794	3.82	24.06	0.747	8.71	13.16	1234
Total Debt	16.29	35.55	49.92	49.26	41.72	21.43	1234
Net Debt	12.57	29.16	32.52	2.65	18.36	-8.99	1234

Market is Open

After-Hours Quote

Market is Open

After-Hours Quote

Codex DNA, Inc. Balance Sheet Statement Quarterly